6505-01-123-2287 ( NDC00781-1804-13 , NDC51079-0027-20 , NDC53489-0141-01 , NDC00677-0675-01 , QUINAGLUTE DURA-TAB , NDC50419-0101-11 , NDC53489-0141-01 , NDC00054-8749-25 , NDC53489-0141-01 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-123-2287 | 6505 | 011232287 | QUINIDINE GLUCONATE EXTENDED-REL | 4258 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| EXQT | EXTERIOR CONTAINER QUANTITY | 24 |
| PKTY | UNIT PACKAGE TYPE | PACKAGE |
| THPE | THERAPEUTIC EQUIVALENT | ANY A RATED DRUG |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS 324MG I.S. 100S |
| SUCB | UNIT OF ISSUE CUBE | 0.0065 CUBIC FEET |
| ECWT | EXTERIOR CONTAINER WEIGHT | 7.00 POUNDS |
| FEAT | SPECIAL FEATURES | 100 TABLETS |
| SUWT | UNIT OF ISSUE WEIGHT | 0.2917 POUNDS |
| CQCT | PRIMARY CONTAINER TYPE | STRIP |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT |
| EXME | EXTERIOR CONTAINER CUBIC MEASURE | 0.1559 CUBIC FEET |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00781-1804-13 | 0THL4 | A | 2 | 5 | 4 | ZZ | |
| NDC51079-0027-20 | 65751 | A | 2 | 5 | 4 | ZZ | |
| NDC53489-0141-01 | 00E55 | A | 1 | 3 | 4 | ZZ | |
| NDC00677-0675-01 | 59225 | A | 2 | 5 | 4 | ZZ | |
| QUINAGLUTE DURA-TAB | 59463 | A | 1 | 5 | 6 | 54 | |
| NDC50419-0101-11 | 59463 | A | 2 | 3 | 6 | 54 | |
| NDC53489-0141-01 | 0A529 | A | 2 | 5 | 4 | ZZ | |
| NDC00054-8749-25 | 34471 | A | 2 | 5 | 4 | ZZ | |
| NDC53489-0141-01 | 0A539 | A | 2 | 5 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00781-1804-13 | 0THL4 | SANDOZ INC. | F | A |
| NDC51079-0027-20 | 65751 | UDL LABORATORIES, INC. | A | A |
| NDC53489-0141-01 | 00E55 | CARDINAL HEALTH INC. | F | A |
| NDC00677-0675-01 | 59225 | BAXTER HEALTHCARE CORP | A | A |
| QUINAGLUTE DURA-TAB | 59463 | BAYER HEALTHCARE PHARMACEUTICALS | A | A |
| NDC50419-0101-11 | 59463 | BAYER HEALTHCARE PHARMACEUTICALS | A | A |
| NDC53489-0141-01 | 0A529 | DISTRIBUTION CENTER INC | A | A |
| NDC00054-8749-25 | 34471 | BOEHRINGER INGELHEIM ROXANE INC. | A | A |
| NDC53489-0141-01 | 0A539 | MUTUAL PHARMACEUTICAL COMPANY IN | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 12/08/1 | P | 3004909120 | 4258 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DN | 9B----- | N | R | REFER TO NON-STD NON-DMSB REV | |
| VA | V | K | U/I CONTAINS 100 TT | ||
| DF | ------- | F | K | U/I CONTAINS 100 TT | |
| DS | N | I | K | U/I CONTAINS 100 TT | |
| DA | Z | C2201X- | A | K | U/I CONTAINS 100 TT |
| DN | 9B----- | N | K | U/I CONTAINS 100 TT |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | 0 | PG | M | U | V | |||
| DN | SMS | L | 1 | PG | M | U | 9B----- | N | |
| DF | SMS | L | 1 | PG | M | U | ------- | F | |
| DS | SMS | L | 1 | PG | M | U | D | ||
| DA | SMS | L | 1 | PG | M | U | Z | C2201X- | A |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|---|---|---|---|
| C | 2 | 2 | 01 | X |
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 058770 | Z | 33400 | W | 532 | Z | 9 | A | M | Z | DRUGS/MEDICINES/VITAMINS NOI |